신생아 급성 신부전의 치료
Treatment of Acute Renal Failure in Neonate
0
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
Acute renal failure (ARF) is common in the neonatal period, however, there are no uniform treatment strategies of ARF. The main treatment strategies are conservative management including medical treatment and the renal replacement therapy. Because ARF in the newborn is commonly acquired by hypoxic ischemic injury and toxic insults, removal of all the offending causes is important. Aminoglycoside, indomethacin, and amphotericin-B are the most common nephrotoxic drugs of ARF. To relieve the possible prerenal ARF, initial fluid challenge can be followed by diuretics. If there is no response, fluid restriction and correction of electrolyte imbalance should begin. Adequate nutritional support and drug dosing according to the pharmacokinetics of such drugs will be difficult problems. Renal replacement therapies may be provided by peritoneal dialysis, intermittent hemodialy
Abstract
Acute renal failure (ARF) is common in the neonatal period, however, there are no uniform treatment strategies of ARF. The main treatment strategies are conservative management including medical treatment and the renal replacement therapy. Because ARF in the newborn is commonly acquired by hypoxic ischemic injury and toxic insults, removal of all the offending causes is important. Aminoglycoside, indomethacin, and amphotericin-B are the most common nephrotoxic drugs of ARF. To relieve the possible prerenal ARF, initial fluid challenge can be followed by diuretics. If there is no response, fluid restriction and correction of electrolyte imbalance should begin. Adequate nutritional support and drug dosing according to the pharmacokinetics of such drugs will be difficult problems. Renal replacement therapies may be provided by peritoneal dialysis, intermittent hemodialy
참고문헌 (39)
- Andreoli SP, "Acute renal failure in the newborn", Semin Perinatol, 28, pp.112~123 (2004)
- Basile DP, "Renal ischemic injury results in permanent damage to peritubular capillaries and influences long-term function", Am J Physiol Renal Physiol, 281, pp.887~899 (2001)
- Mehta RL, "Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury", Crit Care, 11, pp.31~ (2007)
- Bellomo R, "Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group", Crit Care, 8, pp.204~212 (2004)
- Akcan-Arikan A, "Modified RIFLE criteria in critically ill children with acute kidney injury", Kidney Int, 71, pp.1028~1035 (2007)
- Askenazi DJ, "Acute kidney injury in critically ill newborns: what do we know? What do we need to learn?", Pediatr Nephrol, 24, pp.265~274 (2009)
- Ronco C, "Critical care nephrology in pediatrics. In: Critical care nephrology. 2nd ed", pp.2009, Saunders
- Allegaert K, "Nonselective cyclo-oxygenase inhibitors and glomerular filtration rate in preterm neonates", Pediatr Nephrol, 20, pp.1557~1561 (2005)
- Ohlsson A, "Ibuprofen for the treatment of patent ductus arteriosus in preterm and", or low birth weight infants, 2010
- Prins I, "Low-dose dopamine in neonatal and pediatric intensive care: a systematic review", Intensive Care Med, 27, pp.206~210 (2001)
- Kellum JA, "Use of dopamine in acute renal failure: a meta-analysis", Crit Care Med, 29, pp.1526~1531 (2001)
- Bellomo R, "Lowdose dopamine in patients with early renal dysfunction: a placebocontrolled randomised trial. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group", Lancet, 356, pp.2139~2143 (2000)
- Lauschke A, "'Low-dose' dopamine worsens renal perfusion in patients with acute renal failure", Kidney Int, 69, pp.1669~1674 (2006)
- Albanese J, "Renal effects of norepinephrine in septic and nonseptic patients", Chest, 126, pp.534~539 (2004)
- Marshall J, "Preliminary experience with nesiritide in the pediatric population", J Intensive Care Med, 19, pp.164~170 (2004)
- Moffett BS, "Renal effects of fenoldopam in critically ill pediatric patients: A retrospective review", Pediatr Crit Care Med, 9, pp.403~406 (2008)
- Finfer S, "A comparison of albumin and saline for fluid resuscitation in the intensive care unit", N Engl J Med, 350, pp.2247~2256 (2004)
- Dubois MJ, "Albumin administration improves organ function in critically ill hypoalbuminemic patients: A prospective, randomized, controlled, pilot study", Crit Care Med, 34, pp.2536~2540 (2006)
- Moghal NE, "Furosemide and acute kidney injury in neonates", Arch Dis Child Fetal Neonatal Ed, 93, pp.313~316 (2008)
- Sutherland SM, "Fluid overload and mortality in children receiving continuous renal replacement therapy: the prospective pediatric continuous renal replacement therapy registry", Am J Kidney Dis, 55, pp.316~325 (2010)
- Goldstein SL, "Pediatric patients with multi-organ dysfunction syndrome receiving continuous renal replacement therapy", Kidney Int, 67, pp.653~658 (2005)
- Moghal NE, "Management of acute renal failure in the newborn", Semin Fetal Neonatal Med, 11, pp.207~213 (2006)
- Kiessling SG, "Acute kidney injury. In : Pediatric nephrology in the ICU" (2009), Springer
- Jenik AG, "A randomized, double-blind, placebo-controlled trial of the effects of prophylactic theophylline on renal function in term neonates with perinatal asphyxia", Pediatrics, 105, pp.45~ (2000)
- Bakr AF, "Prophylactic theophylline to prevent renal dysfunction in newborns exposed to perinatal asphyxia--a study in a developing country", Pediatr Nephrol, 20, pp.1249~1252 (2005)
- Yu JE, "Acute peritoneal dialysis in very low birth weight neonates using a vascular catheter", Pediatr Nephrol, 25, pp.367~371 (2010)
- Kunzendorf U, "Novel aspects of pharmacological therapies for acute renal failure", Drugs, 70, pp.1099~1114 (2010)
- Fliser D, "EPO: renoprotection beyond anemia correction", Pediatr Nephrol, 21, pp.1785~1789 (2006)
- Endre ZH, "Early intervention with erythropoietin does not affect the outcome of acute kidney injury (the EARLYARF trial)", Kidney Int, 77, pp.1020~1030 (2010)
- Song YR, "Prevention of acute kidney injury by erythropoietin in patients undergoing coronary artery bypass grafting: a pilot study", Am J Nephrol, 30, pp.253~260 (2009)
- Kien ND, "Cardiovascular function during induced hypotension by fenoldopam or sodium nitroprusside in anesthetized dogs", Anesth Analg, 74, pp.72~78 (1992)
- Tumlin JA, "Impaired blood flow in acute kidney injury: pathophysiology and potential efficacy of intrarenal vasodilator therapy", Curr Opin Crit Care, 15, pp.514~519 (2009)
- Costello JM, "Initial experience with fenoldopam after cardiac surgery in neonates with an insufficient response to conventional diuretics", Pediatr Crit Care Med, 7, pp.28~33 (2006)
- Yoder SE, "An evaluation of off-label fenoldopam use in the neonatal intensive care unit", Am J Perinatol, 26, pp.745~750 (2009)
- Haase M, "Phase II, randomized, controlled trial of highdose N-acetylcysteine in high-risk cardiac surgery patients", Crit Care Med, 35, pp.1324~1331 (2007)
- Nigwekar SU, "Atrial natriuretic peptide for management of acute kidney injury: a systematic review and meta-analysis", Clin J Am Soc Nephrol, 4, pp.261~272 (2009)
- Song JH, "The bioartificial kidney in the treatment of acute kidney injury", Curr Drug Targets, 10, pp.1227~1234 (2009)
- Imai N, "Cellular therapy of kidney diseases", Semin Dial, 22, pp.629~635 (2009)
- Chhabra P, "The use of stem cells in kidney disease", Curr Opin Organ Transplant, 14, pp.72~78 (2009)